A Case of Dural Arteriovenous Fistula Following Cerebral Venous Sinus Thrombosis Associated with the COVID-19 Vaccine

DOI Web Site Web Site 参考文献18件
  • Aoyama Jiro
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Iha Hiroto
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Ishikawa Mariko
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Sagawa Hirotaka
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Hirai Sakyo
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Fujita Kyohei
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Fujii Shoko
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • Sumita Kazutaka
    Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan

この論文をさがす

抄録

<p>Objective: Cerebral venous sinus thrombosis (CVST) is one of the rare and severe complications of coronavirus disease 2019 (COVID-19) vaccines. CVST has also been reported to develop into dural arteriovenous fistula; however, there were no reports of dural arteriovenous fistula associated with COVID-19 vaccine-induced cerebral venous sinus thrombosis. Here, we describe a rare case of a transverse–sigmoid sinus dural arteriovenous fistula followed by CVST due to COVID-19 vaccination.</p><p>Case Presentation: A 70-year-old patient presented with headache five days after receiving a second dose of COVID-19 vaccine. MRI showed a CVST in the superior sagittal sinus, left transverse sinus, and left sigmoid sinus. His headache improved after the administration of anticoagulant therapy. Six months later, a similar headache recurred, and cerebral angiography demonstrated a dural arteriovenous fistula in the left transverse sigmoid sinus and convexity dural arteriovenous fistulas in the left parietal cortex. The patient was treated twice with two sessions of transarterial embolization, and the shunts were completely occluded. His symptoms improved, and he was discharged with a modified Rankin Scale score of 0.</p><p>Conclusion: Dural arteriovenous fistula can develop after CVST in association with COVID-19 vaccination.</p>

収録刊行物

参考文献 (18)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ